疫学における人工知能の世界市場レポート 2025年

疫学における人工知能市場規模は、今後数年間で飛躍的な成長が見込まれます。2029年にはCAGR31.0％で24億8,000万米ドルに成長します。予測期間の成長は、データ統合の課題、人口増加、世界ヘルスセキュリティ投資、デジタルヘルス導入、ワンヘルスアプローチ、デジタルコンタクトトレースに起因します。予測期間の主な動向には、計算能力の進歩、データ収集における技術革新、テクノロジー企業との連携、リアルタイムデータ共有プラットフォーム、aiアルゴリズムの進歩、リモートセンシング技術の進歩、疫学データセキュリティのためのブロックチェーンなどが含まれます。

慢性疾患の有病率の増加が予想されることから、疫学市場における人工知能の今後の成長が期待されます。慢性疾患とは、持続する健康状態や長期にわたる影響を及ぼす健康状態のことで、一般的には3カ月以上持続し、時間の経過とともに悪化することが多いです。AIは、リスク予測、疾患進行のモデル化、早期発見、診断など、慢性疾患疫学のさまざまな側面で重要な役割を果たしています。例えば、国連（UN）の2023年5月の報告書によると、米国では慢性疾患が死亡者10人のうち7人を占め、年間170万人以上が死亡しています。したがって、慢性疾患の負担増は疫学市場における人工知能の成長を促進すると予測されます。

遠隔医療の利用拡大が、今後数年間の疫学市場における人工知能の成長を促進すると予想されます。遠隔医療とは、通信技術を通じて遠隔地から医療サービスを提供することを指し、一般的には音声、ビデオ、その他の通信手段を通じて患者とヘルスケアプロバイダー間で医療情報をトランスミッションすることが含まれます。疫学における遠隔医療と人工知能（AI）の組み合わせは、公衆衛生上の問題に対処するためのプロアクティブでデータ駆動型のアプローチを可能にする強力な相乗効果を生み出すことができます。特にアウトブレイクやパンデミック時に、健康関連データを効率的に監視、評価、対応する能力を高める。例えば、2023年2月、米国のデジタルヘルス新興企業を支援するシードファンドであるロックヘルスは、2022年に回答者の80％が生活のどこかで遠隔医療を利用したことがあり、2021年の72％から8ポイント増加したという調査結果を報告しました。遠隔医療の利用は女性の間でも増加しており、女性回答者の82％が遠隔医療を利用したことがあると回答し、2021年から9ポイント上昇しました。したがって、遠隔医療の利用が増加していることが、疫学における人工知能市場の成長を促進しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界疫学における人工知能PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の疫学における人工知能市場：成長率分析
• 世界の疫学における人工知能市場の実績：規模と成長, 2019-2024
• 世界の疫学における人工知能市場の予測：規模と成長, 2024-2029, 2034F
• 世界疫学における人工知能総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の疫学における人工知能市場：コンポーネント別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ソフトウェア
• サービス
• 世界の疫学における人工知能市場：展開別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ウェブベース
• クラウドベース
• 世界の疫学における人工知能市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 感染予測と予報
• 疾病および症候群の監視
• 世界の疫学における人工知能市場：最終用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 政府および州政府機関
• 調査室
• 製薬およびバイオテクノロジー企業
• ヘルスケア提供者
• 世界の疫学における人工知能市場、ソフトウェアのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• データ分析プラットフォーム
• 予測モデリングツール
• 地理情報システム（GIS）
• 監視システム
• レポートおよび視覚化ツール
• 世界の疫学における人工知能市場、サービスの種類別の細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
• コンサルティングサービス
• 実装および統合サービス
• データ管理およびサポートサービス
• トレーニングおよび能力開発サービス

第7章 地域別・国別分析

• 世界の疫学における人工知能市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の疫学における人工知能市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 疫学における人工知能市場：競合情勢
• 疫学における人工知能市場：企業プロファイル
  • Apple Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Alphabet Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Microsoft Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Facebook Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Pfizer Inc.
• Johnson & Johnson Services Inc.
• Amazon Web Services Inc.
• General Electric Company
• Google LLC
• Intel Corporation
• IBM Corporation
• Merck & Co. Inc.
• Novartis International AG
• Sanofi S.A
• Bristol Myers Squibb Company
• AstraZeneca PLC
• Oracle Corporation
• GlaxoSmithKline plc
• NVIDIA Corporation

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 疫学における人工知能市場2029：新たな機会を提供する国
• 疫学における人工知能市場2029：新たな機会を提供するセグメント
• 疫学における人工知能市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

The application of artificial intelligence (AI) in epidemiology involves utilizing AI techniques and tools to enhance and optimize epidemiological research as well as public health interventions. AI in epidemiology aids in the analysis of extensive datasets, the identification of patterns and trends, support for decision-making processes, and the prediction of disease outbreaks to facilitate disease prevention, monitoring, and control.

The primary components of artificial intelligence in epidemiology consist of software and services. Software encompasses a set of programs, instructions, and data that enable a computer or other electronic device to perform specific tasks or operations. Software plays a pivotal role in the implementation of AI in epidemiology, facilitating the analysis of large datasets, modeling the spread of diseases, and making predictions for public health interventions. These software applications are deployed in web-based and cloud-based modes for purposes such as infection prediction and forecasting, disease surveillance, and syndromic surveillance. End-users of such applications include government and state agencies, research laboratories, pharmaceutical and biotechnology companies, as well as healthcare providers.

The artificial intelligence in epidemiology research report is one of a series of new reports from The Business Research Company that provides artificial intelligence in epidemiology market statistics, including the artificial intelligence in epidemiology industry's global market size, regional shares, competitors with an artificial intelligence in epidemiology market share, detailed artificial intelligence in epidemiology market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence in epidemiology industry. This artificial intelligence in epidemiology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The artificial intelligence in epidemiology market size has grown exponentially in recent years. It will grow from $0.66 billion in 2024 to $0.84 billion in 2025 at a compound annual growth rate (CAGR) of 28.0%. The growth in the historic period can be attributed to emergence of big data, globalization and travel, public health surveillance needs, outbreak response challenges, emergence of novel pathogens

The artificial intelligence in epidemiology market size is expected to see exponential growth in the next few years. It will grow to $2.48 billion in 2029 at a compound annual growth rate (CAGR) of 31.0%. The growth in the forecast period can be attributed to data integration challenges, population growth, global health security investments, digital health adoption, one health approach, digital contact tracing. Major trends in the forecast period include advancements in computational power, technological innovations in data collection, collaboration with technology companies, real-time data sharing platforms, advancements in ai algorithms, advancements in remote sensing technologies, blockchain for epidemiological data security.

The anticipated increase in the prevalence of chronic diseases is expected to drive the growth of artificial intelligence in the epidemiology market in the future. Chronic diseases are health conditions that persist or have long-lasting effects, typically lasting for three months or more and often worsening over time. AI plays a crucial role in various aspects of chronic disease epidemiology, including risk prediction, modeling disease progression, early detection, and diagnosis. For example, a May 2023 report from The United Nations (UN) stated that chronic diseases account for seven out of 10 deaths in the US, causing over 1.7 million deaths annually. Therefore, the rising burden of chronic diseases is projected to fuel the growth of artificial intelligence in the epidemiology market.

The growing usage of telemedicine is expected to drive the growth of artificial intelligence in the epidemiology market in the coming years. Telemedicine refers to the delivery of medical services remotely through telecommunications technology, involving the transmission of medical information between patients and healthcare providers, typically via audio, video, or other communication methods. The combination of telemedicine and artificial intelligence (AI) in epidemiology can create a powerful synergy that enables a proactive and data-driven approach to addressing public health issues. It enhances the ability to efficiently monitor, assess, and respond to health-related data, particularly during outbreaks or pandemics. For example, in February 2023, Rock Health, a US-based seed fund supporting digital health startups, reported in a survey that 80% of respondents had accessed telemedicine at some point in their lives in 2022, marking an 8-percentage point increase from 72% in 2021. Telemedicine use also increased among women, with 82% of female respondents indicating they had utilized telemedicine, a 9-percentage point rise from 2021. Therefore, the increasing usage of telemedicine is driving growth in the artificial intelligence in epidemiology market.

A notable trend gaining popularity in the artificial intelligence in epidemiology market is the development of specialized AI-based technologies for disease management. Key companies in this market are focusing on creating innovative technologies, such as AI-driven imaging platforms for disease management, to solidify their market position. For instance, in April 2023, Twinn.health, a US-based company specializing in fitness, AI, and machine learning, launched an AI-driven imaging platform for the early detection of age-related diseases. This platform, the first to incorporate magnetic resonance imaging (MRI) data for evaluating frailty risk, serves as a potent tool for early intervention and prevention by detecting age-related disorders earlier than traditional molecular signals and aiding in their management at an early stage.

Major companies in the artificial intelligence in epidemiology market are concentrating on innovative products, including stroke scoring tools, to better cater to the needs of their existing consumers. Stroke scoring tools are clinical assessments used by healthcare professionals to quickly and objectively evaluate the severity of a stroke. For example, in November 2022, Koninklijke Philips N.V., a Netherlands-based medical technology company, introduced the AI-powered CT ASPECT Scoring tool. This tool, applied to non-contrast CT scans, detects early indicators of brain infarction in the treatment of ischemic stroke patients. The program employs AI to automatically identify ASPECTS brain regions and generates an ASPECT score communicated directly to the Picture Archiving and Communication System (PACS). Philips also unveiled its next-generation Advanced Visualization Workspace, including a new cardiac MR Suite with a redesigned workflow and user interface.

In January 2022, Glooko Inc., a US-based digital health company specializing in diabetes management solutions, acquired Xbird for an undisclosed amount. With this acquisition, Glooko aims to reinforce its commitment to machine learning and personalized digital coaching for patients with chronic conditions. Xbird, a Berlin-based company engaged in health AI, focuses on developing JITAI (Just in Time Adaptive Intervention) technologies for proactive healthcare interventions and disease surveillance.

Major companies operating in the artificial intelligence in epidemiology market include Apple Inc., Alphabet Inc., Microsoft Corporation, Facebook Inc., Roche Holding AG, Pfizer Inc., Johnson & Johnson Services Inc., Amazon Web Services Inc., General Electric Company, Google LLC, Intel Corporation, IBM Corporation, Merck & Co. Inc., Novartis International AG, Sanofi S.A, Bristol Myers Squibb Company, AstraZeneca PLC, Oracle Corporation, GlaxoSmithKline plc, NVIDIA Corporation, Bayer Healthcare, Siemens Healthineers AG, Cogniant Technology Solutions Corporation, Koninklijke Philips N.V., SAS Institute Inc., Epic Systems Corporation, Cerner Corporation, eClinicalWorks LLC, Meditech, Komodo Health, Metabiota Inc.

North America was the largest region in the artificial intelligence in epidemiology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in epidemiology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the artificial intelligence in epidemiology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The artificial intelligence in epidemiology market consists of revenues earned by entities by providing disease surveillance and management, predictive modeling, and risk assessment. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence in epidemiology market also includes sales of real-time monitoring systems and image analysis systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Intelligence In Epidemiology Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on artificial intelligence in epidemiology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial intelligence in epidemiology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The artificial intelligence in epidemiology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Component: Software; Services
• 2) By Deployment: Web-Based; Cloud-Based
• 3) By Application: Infection Prediction And Forecasting; Disease And Syndromic Surveillance
• 4) By End-Use: Government And State Agencies; Research Laboratories; Pharmaceutical And Biotechnology Companies; Healthcare Providers
• Subsegments:
• 1) By Software: Data Analytics Platforms; Predictive Modeling Tools; Geographic Information Systems (GIS); Surveillance Systems; Reporting And Visualization Tools
• 2) By Services: Consulting Services; Implementation And Integration Services; Data Management And Support Services; Training And Capacity Building Services
• Companies Mentioned: Apple Inc.; Alphabet Inc.; Microsoft Corporation; Facebook Inc.; Roche Holding AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Artificial Intelligence In Epidemiology Market Characteristics

3. Artificial Intelligence In Epidemiology Market Trends And Strategies

4. Artificial Intelligence In Epidemiology Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Artificial Intelligence In Epidemiology Growth Analysis And Strategic Analysis Framework

• 5.1. Global Artificial Intelligence In Epidemiology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Artificial Intelligence In Epidemiology Market Growth Rate Analysis
• 5.4. Global Artificial Intelligence In Epidemiology Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Artificial Intelligence In Epidemiology Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Artificial Intelligence In Epidemiology Total Addressable Market (TAM)

6. Artificial Intelligence In Epidemiology Market Segmentation

• 6.1. Global Artificial Intelligence In Epidemiology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Software
• Services
• 6.2. Global Artificial Intelligence In Epidemiology Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Web-Based
• Cloud-Based
• 6.3. Global Artificial Intelligence In Epidemiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Infection Prediction And Forecasting
• Disease And Syndromic Surveillance
• 6.4. Global Artificial Intelligence In Epidemiology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Government And State Agencies
• Research Laboratories
• Pharmaceutical And Biotechnology Companies
• Healthcare Providers
• 6.5. Global Artificial Intelligence In Epidemiology Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Data Analytics Platforms
• Predictive Modeling Tools
• Geographic Information Systems (GIS)
• Surveillance Systems
• Reporting And Visualization Tools
• 6.6. Global Artificial Intelligence In Epidemiology Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Consulting Services
• Implementation And Integration Services
• Data Management And Support Services
• Training And Capacity Building Services

7. Artificial Intelligence In Epidemiology Market Regional And Country Analysis

• 7.1. Global Artificial Intelligence In Epidemiology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Artificial Intelligence In Epidemiology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Artificial Intelligence In Epidemiology Market

• 8.1. Asia-Pacific Artificial Intelligence In Epidemiology Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Artificial Intelligence In Epidemiology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Artificial Intelligence In Epidemiology Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Artificial Intelligence In Epidemiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Artificial Intelligence In Epidemiology Market

• 9.1. China Artificial Intelligence In Epidemiology Market Overview
• 9.2. China Artificial Intelligence In Epidemiology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Artificial Intelligence In Epidemiology Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Artificial Intelligence In Epidemiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Artificial Intelligence In Epidemiology Market

• 10.1. India Artificial Intelligence In Epidemiology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Artificial Intelligence In Epidemiology Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Artificial Intelligence In Epidemiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Artificial Intelligence In Epidemiology Market

• 11.1. Japan Artificial Intelligence In Epidemiology Market Overview
• 11.2. Japan Artificial Intelligence In Epidemiology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Artificial Intelligence In Epidemiology Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Artificial Intelligence In Epidemiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Artificial Intelligence In Epidemiology Market

• 12.1. Australia Artificial Intelligence In Epidemiology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Artificial Intelligence In Epidemiology Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Artificial Intelligence In Epidemiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Artificial Intelligence In Epidemiology Market

• 13.1. Indonesia Artificial Intelligence In Epidemiology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Artificial Intelligence In Epidemiology Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Artificial Intelligence In Epidemiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Artificial Intelligence In Epidemiology Market

• 14.1. South Korea Artificial Intelligence In Epidemiology Market Overview
• 14.2. South Korea Artificial Intelligence In Epidemiology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Artificial Intelligence In Epidemiology Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Artificial Intelligence In Epidemiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Artificial Intelligence In Epidemiology Market

• 15.1. Western Europe Artificial Intelligence In Epidemiology Market Overview
• 15.2. Western Europe Artificial Intelligence In Epidemiology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Artificial Intelligence In Epidemiology Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Artificial Intelligence In Epidemiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Artificial Intelligence In Epidemiology Market

• 16.1. UK Artificial Intelligence In Epidemiology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Artificial Intelligence In Epidemiology Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Artificial Intelligence In Epidemiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Artificial Intelligence In Epidemiology Market

• 17.1. Germany Artificial Intelligence In Epidemiology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Artificial Intelligence In Epidemiology Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Artificial Intelligence In Epidemiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Artificial Intelligence In Epidemiology Market

• 18.1. France Artificial Intelligence In Epidemiology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Artificial Intelligence In Epidemiology Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Artificial Intelligence In Epidemiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Artificial Intelligence In Epidemiology Market

• 19.1. Italy Artificial Intelligence In Epidemiology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Artificial Intelligence In Epidemiology Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Artificial Intelligence In Epidemiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Artificial Intelligence In Epidemiology Market

• 20.1. Spain Artificial Intelligence In Epidemiology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Artificial Intelligence In Epidemiology Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Artificial Intelligence In Epidemiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Artificial Intelligence In Epidemiology Market

• 21.1. Eastern Europe Artificial Intelligence In Epidemiology Market Overview
• 21.2. Eastern Europe Artificial Intelligence In Epidemiology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Artificial Intelligence In Epidemiology Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Artificial Intelligence In Epidemiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Artificial Intelligence In Epidemiology Market

• 22.1. Russia Artificial Intelligence In Epidemiology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Artificial Intelligence In Epidemiology Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Artificial Intelligence In Epidemiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Artificial Intelligence In Epidemiology Market

• 23.1. North America Artificial Intelligence In Epidemiology Market Overview
• 23.2. North America Artificial Intelligence In Epidemiology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Artificial Intelligence In Epidemiology Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Artificial Intelligence In Epidemiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Artificial Intelligence In Epidemiology Market

• 24.1. USA Artificial Intelligence In Epidemiology Market Overview
• 24.2. USA Artificial Intelligence In Epidemiology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Artificial Intelligence In Epidemiology Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Artificial Intelligence In Epidemiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Artificial Intelligence In Epidemiology Market

• 25.1. Canada Artificial Intelligence In Epidemiology Market Overview
• 25.2. Canada Artificial Intelligence In Epidemiology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Artificial Intelligence In Epidemiology Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Artificial Intelligence In Epidemiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Artificial Intelligence In Epidemiology Market

• 26.1. South America Artificial Intelligence In Epidemiology Market Overview
• 26.2. South America Artificial Intelligence In Epidemiology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Artificial Intelligence In Epidemiology Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Artificial Intelligence In Epidemiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Artificial Intelligence In Epidemiology Market

• 27.1. Brazil Artificial Intelligence In Epidemiology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Artificial Intelligence In Epidemiology Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Artificial Intelligence In Epidemiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Artificial Intelligence In Epidemiology Market

• 28.1. Middle East Artificial Intelligence In Epidemiology Market Overview
• 28.2. Middle East Artificial Intelligence In Epidemiology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Artificial Intelligence In Epidemiology Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Artificial Intelligence In Epidemiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Artificial Intelligence In Epidemiology Market

• 29.1. Africa Artificial Intelligence In Epidemiology Market Overview
• 29.2. Africa Artificial Intelligence In Epidemiology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Artificial Intelligence In Epidemiology Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Artificial Intelligence In Epidemiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Artificial Intelligence In Epidemiology Market Competitive Landscape And Company Profiles

• 30.1. Artificial Intelligence In Epidemiology Market Competitive Landscape
• 30.2. Artificial Intelligence In Epidemiology Market Company Profiles
  • 30.2.1. Apple Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Alphabet Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Microsoft Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Facebook Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis

31. Artificial Intelligence In Epidemiology Market Other Major And Innovative Companies

• 31.1. Pfizer Inc.
• 31.2. Johnson & Johnson Services Inc.
• 31.3. Amazon Web Services Inc.
• 31.4. General Electric Company
• 31.5. Google LLC
• 31.6. Intel Corporation
• 31.7. IBM Corporation
• 31.8. Merck & Co. Inc.
• 31.9. Novartis International AG
• 31.10. Sanofi S.A
• 31.11. Bristol Myers Squibb Company
• 31.12. AstraZeneca PLC
• 31.13. Oracle Corporation
• 31.14. GlaxoSmithKline plc
• 31.15. NVIDIA Corporation

32. Global Artificial Intelligence In Epidemiology Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Artificial Intelligence In Epidemiology Market

34. Recent Developments In The Artificial Intelligence In Epidemiology Market

35. Artificial Intelligence In Epidemiology Market High Potential Countries, Segments and Strategies

• 35.1 Artificial Intelligence In Epidemiology Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Artificial Intelligence In Epidemiology Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Artificial Intelligence In Epidemiology Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer